Infection Control - Global Strategic Business Report

The global market for Infection Control was valued at US$56.3 Billion in 2024 and is projected to reach US$83.4 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Infection Control Market - Key Trends & Drivers Summarized

What Defines the Scope and Importance of Infection Control Today?

Infection control is a critical discipline within healthcare that aims to prevent or stop the spread of infections in healthcare facilities and communities. This field encompasses various practices, processes, and procedures used to minimize the risk of infection. It involves the use of disinfection methods, sterilization procedures, and sanitation practices to protect patients and healthcare workers alike. Infection control is essential not only in hospitals but also in other settings such as clinics, nursing homes, and at home, especially when caring for the elderly or those with weakened immune systems. The significance of infection control has been underscored by recent global health crises, where the lack of proper practices led to widespread outbreaks, highlighting the need for stringent and effective infection control measures.

How Have Pandemics Reinforced the Necessity for Robust Infection Control Measures?

The COVID-19 pandemic has dramatically transformed the landscape of infection control, bringing unprecedented attention and resources to this field. Healthcare facilities worldwide have revised and updated their infection control protocols to handle the surge in patients while preventing the spread of the virus within and beyond their walls. This situation has accelerated innovation in infection control technologies, such as UV-C disinfection, HEPA filters, and advanced personal protective equipment (PPE). Moreover, it has led to increased governmental and institutional investments in training healthcare workers in the best practices for infection prevention and control, which is critical in managing not only the current pandemic but also future outbreaks.

Which Technological Innovations Are Revolutionizing Infection Control?

Technology plays a pivotal role in advancing infection control measures. The development of new diagnostic tools has enabled faster identification of pathogens, which is crucial for effective infection control. Advanced sterilization technology, such as low-temperature plasma sterilization, offers more efficient and safer alternatives to traditional methods, which often involved toxic chemicals or high heat. Robotics and automation have also been introduced in some healthcare settings to decontaminate rooms and equipment more thoroughly and consistently than manual cleaning. Furthermore, information technology has facilitated better tracking and data analysis to monitor infection rates and outcomes, significantly enhancing infection control programs' effectiveness.

What Are the Major Drivers of Growth in the Infection Control Market?

The growth in the infection control market is driven by several factors, including increased awareness of healthcare-associated infections (HAIs), technological advancements in sterilization and disinfection products, and global health crises such as the COVID-19 pandemic. There is a growing demand for effective infection control solutions across various healthcare settings, driven by the need to improve patient safety and meet stringent regulatory standards. Technological innovations have led to the development of more effective and efficient infection control products, which are being rapidly adopted by healthcare facilities worldwide. Additionally, shifts in consumer behavior, particularly the increased emphasis on sanitation and hygiene practices observed in both healthcare workers and the general public, are further propelling the market growth.

Scope of the Study

The report analyzes the Infection Control market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Products & Services (Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products, Other Products & Services); End-Use (Hospitals & Clinics, Pharma & Medical Device Companies, Other End-Uses).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Protective Barriers segment, which is expected to reach US$34.8 Billion by 2030 with a CAGR of a 7.7%. The Sterilization Products & Services segment is also set to grow at 7.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $15.3 Billion in 2024, and China, forecasted to grow at an impressive 8.0% CAGR to reach $12.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as 3M Company, AstraZeneca PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, bioMerieux SA and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Infection Control Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infection Control Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Infection Control Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Some of the 145 major companies featured in this Infection Control market report include:

• 3M Company
• AstraZeneca PLC
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• bioMerieux SA
• AliMed, Inc.
• Baumer SA
• Ansell Ltd.
• Allegion PLC
• Alfred Becht GmbH
• Belimed AG
• A-dec Inc.
• Advanced Sterilization Products
• Ahlstrom-Munksjo
• ABC Dentistry & Orthodontics